Your session is about to expire
← Back to Search
RFA for Thyroid Cancer
Study Summary
This trial will test how well Radiofrequency ablation (RFA) therapy works to treat papillary thyroid carcinoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 1 & 2 trial • 61 Patients • NCT01853618Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.My opposite side vocal cord is paralyzed.Diagnosed using fine needle aspiration (FNA) testing.My cancer has spread to other parts of my body.I have been diagnosed with a type of thyroid cancer that has multiple growths.My scans show I can have RFA therapy with low risk.I have had surgery or radiation treatment on my neck before.My doctor agrees non-surgical treatment is right for me.My neck shape makes it hard for doctors to perform RFA.I have a blood clotting disorder or am on blood thinners.My thyroid nodule is identified as papillary carcinoma.I have health conditions that make general anesthesia too risky for me.The size of the condition being studied is less than 1.5 centimeters.
- Group 1: RFA Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the minimum age requirement for this trial over 45 years old?
"Compliant with the enrollment parameters for this investigation, applicants must be at least 18 years old but not older than 85."
Are there any eligibility criteria that would preclude me from participating in this trial?
"The research team is searching for 5 participants with a diagnosis of papillary thyroid cancer, aged 18-85. The size of the tumour must be <1.5 cm, and non-surgical management should be approved by their medical practitioner."
Is enrollment for this research study currently open?
"According to the clinicaltrials.gov, this medical research is no longer recruiting participants. The study was initially advertised on June 15th 2020 and saw its last update on July 21st 2022. However, there are 228 other trials that are taking in patients at present time."
Share this study with friends
Copy Link
Messenger